Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 11 Search
2023
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Expert Review of Molecular Diagnostics
2023
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
European Archives of Psychiatry and Clinical Neuroscience
2023
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
Current Neuropharmacology
2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Molecular Psychiatry
2022
Various BDNF administrations attenuate SPS-induced anxiety-like behaviors
Neuroscience Letters
2021
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
Journal of Clinical Medicine
2021
The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality
Journal of Psychiatric Research
2021
Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials
Journal of Psychiatric Research
Additional cited-by details will be shown when available from Crossref